Remove Bioethics Remove FDA Remove Governance
article thumbnail

A Brief Quantum Medicine Policy Guide

Bill of Health

The EU AI Act , proposed EU AI Liability Directive , and laws under the European Strategy for Data , such as the Data Governance Act , may also play roles. US Legal Requirements for Quantum-Powered Medical Devices In the United States, some quantum-powered medical devices may be governed under the existing FDA regulatory framework.

FDA 182
article thumbnail

Petrie-Flom Welcomes 2022-2023 Student Fellows

Bill of Health

These five students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from across Harvard. Sarah Gabriele is a second year Master of Bioethics candidate at Harvard Medical School. We are excited to welcome a new group of Student Fellows to the Petrie-Flom Center family. Louis (USA).

Bioethics 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Brief Quantum Medicine Policy Guide

Bill of Health

The EU AI Act , proposed EU AI Liability Directive , and laws under the European Strategy for Data , such as the Data Governance Act , may also play roles. US Legal Requirements for Quantum-Powered Medical Devices In the United States, some quantum-powered medical devices may be governed under the existing FDA regulatory framework.

FDA 130
article thumbnail

Psychedelic Policy on the Federal Level: Key Takeaways from a Petrie-Flom Center Panel

Bill of Health

To navigate the myriad interests and stakes involved in creating federal psychedelic policy, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School convened a virtual panel discussion with three leading psychedelic policy advocates. By James R. A full video of the event is available below.

Bioethics 130
article thumbnail

Public Health Product Hops

Bill of Health

Regulatory and patent exclusivity periods govern the timing of generic entry, and because market share and revenue is often quickly lost upon market entry of generic drugs, extending market exclusivity for any duration can be extremely profitable. Glenn Cohen’s Health Law Policy, Bioethics, and Biotechnology Workshop at HLS.

article thumbnail

Book Review: ‘The Truth Pill: The Myth of Drug Regulation in India’

Bill of Health

In fact, before publishing the book, the authors petitioned the government, highlighting glaring regulatory issues, but the government turned a blind eye. The book relies on primary sources of information — mainly government reports, judicial decisions, and government data.

article thumbnail

What You Need to Know About Marijuana Rescheduling

Bill of Health

Notably, the recommendation was the first statement from a federal government agency that marijuana has a currently accepted medical use and a low potential for abuse. Schedule 3 drugs must be approved by the Food and Drug Administration (FDA,) prescribed by a doctor, and distributed by a pharmacy. Victoria Litman M.Div, J.D.,

FDA 214